KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer.

Carly Strelez, Francesca Battaglin, Rachel Perez, Yan Yang, Christopher Cherry, Joshua Millstein, Ah Young Yoon, John S Chlystek, Ethan Canfield, Bethany Haliday, Curran Shah, Kimya Ghaffarian, Shivani Soni, Hannah Jiang, Roy Lau, Aaron Schatz, Yuyuan Zhou, Daniel Mulkerin, Fang-Shu Ou, Alan P Venook, Federico Innocenti, Josh Neman, Jonathan E Katz, Heinz-Josef Lenz, Shannon M Mumenthaler

Oncogene 44(41) 3924-3938

PMID40851030
PMCIDPMC12500471
DOI10.1038/s41388-025-03546-2
发表日期2025-08-24
摘要

摘要

Alterations in neurotransmitter signaling can influence colorectal cancer (CRC). In a large, randomized Phase III clinical trial (CALGB/SWOG 80405) involving patients with metastatic CRC, high expression of gamma-aminobutyric acid (GABA) pathway gene GAD1 and low expression of ABAT, indicative of a GABAergic environment, were associated with worse progression-free survival and overall survival outcomes. A metastasis map of human cancer cell lines (MetMap) and functional studies using a microfluidic tumor-on-chip platform demonstrated that high GAD1 expression correlates with increased metastatic potential. Knockdown and pharmacological inhibition of GAD1 reduced tumor invasion, while exogenous GABA promoted invasion. Tumor-derived GABA was elevated in Ras-altered tumors. Furthermore, analysis of publicly available data confirmed that higher GAD1 expression is associated with worse outcomes in Ras-mutant tumors. These findings establish a role for GABA signaling in tumor invasiveness, particularly in Ras-altered CRC. This study demonstrates using clinical data to inform new discoveries and highlights the need for advanced preclinical model systems that more accurately reflect human physiology to explore these findings.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。